Pheno- & Genotyping POF (WHO III)

Summary

This study focuses on the phenotyping and genotyping of women with hypergonadotropic ovarian dysfunction (WHO III status).

Conditions

• Premature Ovarian Failure (POF)
• Incipient Ovarian Failure
• Poor Response After Ovarian Hyperstimulation
• Early Menopause
• Hypergonadotropic Amenorrhea

Sponsors & Collaborators

• Erasmus Medical Center

  collaborator OTHER

• Medical Center Alkmaar

  collaborator OTHER

• University Medical Center Groningen

  collaborator OTHER

• Leiden University Medical Center

  collaborator OTHER

• Medisch Spectrum Twente

  collaborator OTHER

• Isala

  collaborator OTHER

• Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands.

  collaborator OTHER

• Amphia Hospital

  collaborator OTHER

• Deventer Ziekenhuis

  collaborator OTHER

• Catharina Ziekenhuis Eindhoven

  collaborator OTHER

• Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  collaborator OTHER

• Academisch Ziekenhuis Maastricht

  collaborator OTHER

• Amsterdam UMC, location VUmc

  collaborator OTHER

• UMC Utrecht

  lead OTHER

Principal Investigators

• Bart CJ Fauser, MD PhD · UMC Utrecht

Eligibility

Min Age

12 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2005-01-31

Primary Completion

2020-06-30

Completion

2020-06-30

Countries

• Netherlands

Study Locations